Latent View Analytics (LATENTVI IN) – Management Meet Update – Navigating the AI shift – BUY
Published on 04 Mar 2026
We reduce our USD revenue estimates by 60bps/90bps for FY27E/FY28E, respectively, due to continued weakness in Hi-Tech and higher concentration mix of Diagnostics, but keep our margin estimates unchanged. The stock is currently trading at 26x/21x of FY27E/FY28E earnings after the recent correction. We assign PE multiple of 32x (40x earlier) to FY28E earnings and arrive at revised TP of Rs490 (Rs630 earlier). Maintain ‘BUY’.
